CareView
ActiveSummary
CareView has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.8m and a net result of €40,973. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 47% of 2356 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability41▲+2
Solvency82▲+1
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €120,000 at 30 days acceptable
Liquidity short (current ratio 0.13 against 0.08 in 2024; short-term debt: 23.6% and cash: 0.2% of total assets), and 43.1% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
56.9%
Return on assets
1.3%
Age of the figures
9 mo
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
19202122232425
2019 to 2025 · latest year €1.8m
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-08-2026, 17 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filingsDeviation from the deadline
2025
17 d late
2024
82 d late
2023
26 d late
2022
31 d late
2021
10 d early
2020
17 d early
2019
7 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 17 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
In the rankings
#5 company by total assets in Sint-Pieters-Woluwe, Health and social work sector#5 company by equity in Sint-Pieters-Woluwe, Health and social work sector
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€40,973▲ 87.3%
2024 · €21,872
Working capital
-€639,803▼ 4.1%
2024 · -€614,765
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€12,194▼ 63.3%-€3,601€16,884€33,163▲ 96.4%€57,052▲ 72.0%
Net result€5,046below the sector's middle half▼ 64.9%-€8,890below the sector's middle half€10,934below the sector's middle half€21,872within the sector's middle half▲ 100%€40,973within the sector's middle half▲ 87.3%
Equity€79,164within the sector's middle half▲ 6.8%€70,275below the sector's middle half▼ 11.2%€81,208below the sector's middle half▲ 15.6%€1.7mabove the sector's middle half▲ 2,022%€1.8mabove the sector's middle half▲ 2.4%
Total assets€1.4mabove the sector's middle half▲ 0.4%€1.4mabove the sector's middle half▲ 0.4%€1.5mwithin the sector's middle half▲ 1.3%€3.1mabove the sector's middle half▲ 111%€3.1mabove the sector's middle half▲ 1.2%
Debt€1.4m=€1.4m▲ 1.1%€1.4m▲ 0.5%€1.3m▼ 2.2%€1.3m▼ 0.3%
Working capital-€279,998▼ 57.1%-€422,546▼ 50.9%-€536,294▼ 26.9%-€614,765▼ 14.6%-€639,803▼ 4.1%
Solvency5.5%below the sector's middle half▲ 0.3pp4.9%below the sector's middle half▼ 0.6pp5.6%below the sector's middle half▲ 0.7pp56.2%within the sector's middle half▲ 50.6pp56.9%within the sector's middle half▲ 0.7pp
Staff (FTE)1below the sector's middle half▲ 150%1below the sector's middle half=1below the sector's middle half=1below the sector's middle half=1within the sector's middle half=
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 72% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.1m
Fixed assets
€3.0m =
Current assets
€92,764 ▲ 64.3%
Equity and liabilities €3.1m
Equity
€1.8m ▲ 2.4%
Debt
€1.3m ▼ 0.3%
Debt's share of the balance-sheet total falls from 43.8% to 43.1%. Equity is higher and debt is lower.
Key figures and ratios
Current ratio
0.13▲
2024 · 0.08
Debt to equity
0.76▼
2024 · 0.78
ROE
2.3%▲
2024 · 1.3%
ROA
1.3%▲
2024 · 0.7%
Debt ≤ 1 year
€732,567▲
2024 · €671,230
Debt > 1 year
€606,144▼
2024 · €672,154
Income taxes
€14,336▲
2024 · €7,596
Staff costs
€5,413▲
2024 · €1,394
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €22,367 | €41,862 | €41,925 | €1,394 | €5,413 | ▲ 288% |
| Other operating charges640/8 | €868 | €868 | €960 | €968 | €1,008 | ▲ 4.2% |
| Gross operating margin9900 | €35,429 | €39,129 | €59,769 | €35,525 | €63,474 | ▲ 78.7% |
| Operating profit (loss)9901 | €12,194 | -€3,601 | €16,884 | €33,163 | €57,052 | ▲ 72.0% |
| Financial income75/76B | €1,371 | €546 | €724 | €0 | €739 | ▲ 615,467% |
| Recurring financial income75 | €1,371 | €34 | €724 | €0 | €739 | ▲ 615,467% |
| Non-recurring financial income76B | €1,371 | €513 | €724 | - | €739 | - |
| Financial charges65/66B | €6,525 | €5,835 | €4,736 | €3,695 | €2,481 | ▼ 32.9% |
| Recurring financial charges65 | €6,525 | €5,835 | €4,736 | €3,695 | €2,481 | ▼ 32.9% |
| Profit (loss) for the period before taxes9903 | €7,040 | -€8,890 | €12,872 | €29,468 | €55,309 | ▲ 87.7% |
| Income taxes67/77 | €1,993 | - | €1,938 | €7,596 | €14,336 | ▲ 88.7% |
| Profit (loss) for the period9904 | €5,046 | -€8,890 | €10,934 | €21,872 | €40,973 | ▲ 87.3% |
| Profit (loss) for the period to be appropriated9905 | €5,046 | -€8,890 | €10,934 | €21,872 | €40,973 | ▲ 87.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.4m | €1.4m | €1.5m | €3.1m | €3.1m | ▲ 1.2% |
| Fixed assets21/28 | €1.4m | €1.4m | €1.4m | €3.0m | €3.0m | = |
| Financial fixed assets28 | €1.4m | €1.4m | €1.4m | €3.0m | €3.0m | = |
| Current assets29/58 | €29,902 | €36,304 | €64,334 | €56,465 | €92,764 | ▲ 64.3% |
| Amounts receivable within one year40/41 | €24,134 | €29,134 | €54,134 | €50,703 | €86,164 | ▲ 69.9% |
| Trade receivables40 | - | - | €25,000 | €26,569 | €50,000 | ▲ 88.2% |
| Other amounts receivable41 | €24,134 | €29,134 | €29,134 | €24,134 | €36,164 | ▲ 49.8% |
| Cash at bank and in hand54/58 | €5,768 | €7,170 | €10,200 | €5,762 | €6,600 | ▲ 14.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.4m | €1.4m | €1.5m | €3.1m | €3.1m | ▲ 1.2% |
| Equity10/15 | €79,164 | €70,275 | €81,208 | €1.7m | €1.8m | ▲ 2.4% |
| Contributions10/11 | €50,000 | €50,000 | €50,000 | €50,000 | €50,000 | = |
| Revaluation surpluses12 | - | - | - | €1.6m | €1.6m | = |
| Reserves13 | €5,000 | €5,000 | €5,000 | €5,000 | €5,000 | = |
| Non-distributable reserves130/1 | €5,000 | €5,000 | €5,000 | €5,000 | €5,000 | = |
| Reserves not available under the articles1311 | - | - | €5,000 | €5,000 | €5,000 | = |
| Other1319 | €5,000 | €5,000 | - | - | - | - |
| Profit (loss) carried forward14 | €24,164 | €15,275 | €26,208 | €48,080 | €89,053 | ▲ 85.2% |
| Amounts payable17/49 | €1.4m | €1.4m | €1.4m | €1.3m | €1.3m | ▼ 0.3% |
| Amounts payable after more than one year17 | €863,837 | €800,979 | €737,097 | €672,154 | €606,144 | ▼ 9.8% |
| Financial debts170/4 | €863,837 | €800,979 | €737,097 | €672,154 | €606,144 | ▼ 9.8% |
| Amounts payable within one year42/48 | €309,900 | €458,850 | €600,628 | €671,230 | €732,567 | ▲ 9.1% |
| Current portion of amounts payable after more than one year42 | €61,841 | €62,858 | €63,882 | €64,943 | €66,011 | ▲ 1.6% |
| Trade debts44 | €673 | €2,870 | €2,845 | €1,955 | €942 | ▼ 51.8% |
| Suppliers440/4 | €673 | €2,870 | €2,845 | €1,955 | €942 | ▼ 51.8% |
| Taxes, remuneration and social security45 | €4,193 | €4,677 | €10,756 | €2,596 | €5,356 | ▲ 106% |
| Taxes450/3 | €1,993 | - | €2,728 | €2,596 | €4,336 | ▲ 67.0% |
| Remuneration and social security454/9 | €2,200 | €4,677 | €8,028 | - | €1,020 | - |
| Other amounts payable47/48 | €243,192 | €388,446 | €523,146 | €601,737 | €660,258 | ▲ 9.7% |
| Accrued charges and deferred income492/3 | €177,000 | €106,200 | €35,400 | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €5,046 | -€8,890 | €10,934 | €21,872 | €40,973 | ▲ 87.3% |
| Operating cash flow (approximation) | €5,046 | -€8,890 | €10,934 | €21,872 | €40,973 | ▲ 87.3% |
| Investment in fixed assets (approximation) | - | €0 | €10,000 | -€1.6m | €0 | ▲ 100% |
| Change in cash | - | €1,402 | €3,030 | -€4,438 | €838 | ▲ 119% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
17-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 17 days late
2025
31-12
Financial
Highest result since 2019net €40,973 ▲87.3%
Operating result €57,052, net result €40,973, both a record.
21-10
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 82 days late
2024
31-12
Financial
Equity above €1mEq €1.7m ▲2,022%
2 profitable years in a row build equity to €1.7m.
26-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 26 days late
2023
31-12
Financial
Back to profitnet €10,934
Net result €10,934 after one loss-making year.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 31 days late
2022
31-12
Financial
Weakest financial yearnet -€8,890
Net result drops to -€8,890, the lowest in the series; recovery starts the following year.
21-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
14-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
24-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Pieters-Woluwe · 1 establishment unit since 2019
Ground area
386 m²
Building footprint
168 m²
Volume, LiDAR
1,895 m³
Parcel 21684B0066/00V011, Brussels · tallest building 14.5 m, ±4 floors. Linked by address, not a title deed.
16
companies at this address
See who is registered here
1 establishment unit
Gebroeders Legrainlaan 85, 1150 Sint-Pieters-Woluwe
since 20192.292.667.848
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21684B0066/00V011 | Brussels | 386 m² | 1 · 167 m² | 14.5 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
2 holdings · 3 subsidiaries in the treeOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 2
-
100%
-
100%
All subsidiaries, including indirect ones 3
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
- GEMAMEDIC 100%
GEMAPHER 100%1 subsidiary
- GEMAPHILIER 100%
According to the 2025 annual accounts of CareView and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
CENTRE DE SANTE INTEGREE "CAP SANTE", a.s.b.l.
BE 0860.058.517
Huy · Eq €1,763,828
Dr. JANSSENS REUMALEX-REUMATOLOGIE, VERZEKERINGSGENEESKUNDE EN MEDISCHE EXPERTISE
BE 0821.306.819
Gent · Eq €1,765,550
DOKTER EGGERS
BE 0478.361.042
Malle · Eq €1,769,417
DIAGNOSECENTRUM VOORKEMPEN
BE 0457.169.413
Zoersel · Eq €1,757,481
Medisch Kabinet Dr. Verhoeven Wim
BE 0634.557.667
Antwerpen · Eq €1,772,426
Of 9,128 companies in sector 86210 we hold annual accounts for 6,335. 3,177 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company (pre-2019)
Founded22-03-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Contact
E-mail
mike.salavracos@gmail.com
Phone
+32496481647
E-invoicing
Not found in the Peppol register
No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.
What can you do?
Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.
If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.